Skip to main content
. 2019 May 31;20(2):1196–1202. doi: 10.3892/mmr.2019.10315

Figure 4.

Figure 4.

Gsk-3β is a target gene of miR-26b-5p. (A) Comparison between miR-26b-5p and 3′-UTR of Gsk-3β; red indicates the complementary site. (B) Dual-luciferase reporter assay; miR-26b inhibited the luciferase activity of WT Gsk-3β, whereas it had no effect on Mut Gsk-3β. *P<0.05. Gsk-3β, glycogen synthase kinase-3β; miR-26b-5p, microRNA-26b-5p; Mut, mutant; NC, negative control; WT, wild-type.